How has childhood cancer research changed since the 1800s?
Cancer has been around for thousands of years. But it's only since the 1800s that we have made progress in understanding and treating it - particularly in children. Read to find out more...
TYAC funds research to help young people with skin cancer
Teenagers and Young Adults with Cancer (TYAC) is proud to announce it has funded two brand-new research projects that will answer questions important to teenagers and young adults with cancer.
New research project will help young people understand their risk of kidney damage
Teenagers and Young Adults with Cancer (TYAC) is proud to have funded its first two research projects to help young people with cancer.
What even is a ‘targeted therapy’ anyway?
Targeted treatments that use drugs to stop cancer cells from growing and spreading. Find out what they are, how they work, and why they are so important...
First of its kind childhood cancer research launches, thanks to CCLG Special Named Funds and Alice’s Arc
Children’s Cancer and Leukaemia Group (CCLG) and Alice’s Arc are proud to announce a new research project that will help support families and clinicians with treatment decisions for relapsed and refractory rhabdomyosarcoma.
How do you test medicines for brain tumours?
Experts from the University of Nottingham have developed a new way of tracking how medicines move in the brain. Find out how this could help get medicines into clinical trials faster...
Can you change the future? We think so.
Research is really about helping patients, families, friends - you. So, in celebration of our first ever research blog post, we will look at how you can impact research.
CCLG partners with NCRI to further childhood cancer research
Children’s Cancer and Leukaemia Group (CCLG) is proud to have become a partner of the National Cancer Research Institute (NCRI).
Family’s fundraising in memory of Ruby funds vital blood cancer research
A pioneering research project funded by a Children’s Cancer and Leukaemia Group (CCLG) Special Named Fund is investigating how the wrong genes are being instructed in patients with T-cell leukaemia in the hope that the knowledge gleaned will inform treatments to stop cancer cells surviving.